SCHEMBL9019197

SCHEMBL9019197

CCN(CC)C(=O)C(NCCNC(C)(C)C)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.45
OPRD1 P41143 2/20 0.43
SLC22A1 O15245 1/20 0.42
CCR2 P41597 1/20 0.39
OGT O15294 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
OPRM1 P35372 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
ADRB2 P07550 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRB3 P13945 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
GLA P06280 1/20 0.36
HPGD P15428 1/20 0.36
RECQL P46063 1/20 0.36
TP53BP1 Q12888 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL9180562 0.94 SMN1; SMN2 (0.40) SMN1; SMN2OPRD1SLC22A1CCR2OGT
SCHEMBL9019226 0.80 SMN1; SMN2 (0.46) SMN1; SMN2OPRD1OPRM1MEN1KMT2A
SCHEMBL9019287 0.69 CCR2 (0.59) SMN1; SMN2SLC22A1CCR2ALDH1A1KDM4E
SCHEMBL16644926 0.69 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL3726123 0.69 SMN1; SMN2 (0.60) SMN1; SMN2OPRD1ALDH1A1MEN1KMT2A
SCHEMBL14015971 0.69 MTOR (0.52) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL29103977 0.68 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL21535462 0.68 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1MEN1KMT2AGAA
SCHEMBL1174449 0.68 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL1174179 0.68 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0581167-B1 Novel arylglycinamide derivatives and preparative processes therefor and their use for treatment of dysuria KYORIN SEIYAKU KK (JP) 1996-10-09 EP disclosed
US-5439919-A Treatment of urinary incontinence KYORIN PHARMACEUTICAL CO., LTD. (JP) 1995-08-08 US disclosed
EP-0581167-A1 Novel arylglycinamide derivatives and preparative processes therefor and their use for treatment of dysuria KYORIN PHARMACEUTICAL CO., LTD. (JP) 1994-02-02 EP disclosed